NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
9 trialsNCT01838317 2021-03-01
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02347813 2020-06-23
Preventing Squamous Cell Skin Cancer
University of Rochester
Phase 2 Completed
NCT03117517 2020-03-02
Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Phase EARLY_PHASE1 Completed
NCT01637935 2018-03-07
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Takeda
Completed
NCT02958956 2018-03-07
Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Takeda
Completed
NCT01655719 2017-10-26
Pioglitazone in Thyroid Cancers
University of Michigan
Phase 2 Completed
NCT00427999 2016-11-21
INV342
Novartis
Phase 2 Completed
NCT01223196 2016-01-11
PIO-TACE
The University of Texas Health Science Center at San Antonio
Phase 4 Completed